DCAL / NSE / Biotechnology & Drugs
Dishman Carbogen Amcis
1Y Price Trend
Key Information
Recommendations
Target High321.15
Target Low129
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk63.37
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Dishman Carbogen Amcis Ltd is Rated Strong Sell Markets Mojo
Dishman Carbogen Amcis Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Dishman Carbogen Amcis Ltd is Rated Strong Sell Markets Mojo
Dishman Carbogen Amcis Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Dishman Carbogen Amcis Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Dishman EGM set for June 19 to approve ECB scanx.trade
Dishman Carbogen Amcis Limited Q4 and Full Year FY26 Earnings Call Overview InvestyWise
Dishman Q4 FY26 net revenue rises 18.9% to ₹8,514 mn scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026

